DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/04/3201-155-161$20.00
DMD 32:155-161, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamaguchi, Y.
Right arrow Articles by Halpert, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamaguchi, Y.
Right arrow Articles by Halpert, J. R.

TOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESIS

Yoshitaka Yamaguchi, Kishore K. Khan1, You Ai He, You Qun He, and James R. Halpert

Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas

The active site topology of heterologously expressed CYP3A4 purified from an Escherichia coli expression system was examined using phenyldiazene. Incubation of CYP3A4 with phenyldiazene and subsequent oxidation yielded all four potential N-phenylprotoporphyrin IX regioisomers derived from attack on an available nitrogen atom in pyrrole rings B, A, C, or D (NB:NA:NC:ND = 6:73:7: 13). Further study using 28 active site mutants showed that substitution of residues closer to the heme, Ala-305, Thr-309, or Ala-370, with a larger residue caused the most drastic changes in regioisomer formation, which reflected the location of each amino acid residue replaced in a CYP3A4 homology model. Previous studies have suggested a conformational change in CYP3A4 upon binding of NADPH-cytochrome P450 reductase (CPR) or cytochrome b5 (b5). Therefore, regioisomer formation was also compared in the absence of redox partners and in the presence of CPR, b5, or both. Formation of all four regioisomers in CYP3A4 wild type, particularly the minor ones, was reduced in the presence of b5. CPR also greatly decreased the three minor isomers but increased the major isomer significantly. The presence of b5 and CPR restored minor isomer formation and suppressed the enhancement of NA formation caused by CPR alone. Interestingly, the effects of the redox partners differed among representative active site mutants. In particular, the increase in NC upon substitution of Ala-370 with Phe was significantly reversed in the presence of redox partners, strongly suggesting that a conformational change occurs around pyrrole ring C due to protein-protein interactions between CYP3A4 and CPR or b5.


Address correspondence to: Dr. Yoshitaka Yamaguchi, Department of Drug Metabolism and Pharmacokinetics, Development Research Laboratories, Shionogi & Co., LTD., 3-1-1, Futaba-cho, Toyonaka, Osaka, 561-0825, Japan. E-mail: yoshitaka.yamaguchi{at}shionogi.co.jp




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. N. Bumpus and P. F. Hollenberg
Investigation of the Mechanisms Underlying the Differential Effects of the K262R Mutation of P450 2B6 on Catalytic Activity
Mol. Pharmacol., October 1, 2008; 74(4): 990 - 999.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Kumar, H. Liu, and J. R. Halpert
Engineering of Cytochrome P450 3A4 for Enhanced Peroxide-Mediated Substrate Oxidation Using Directed Evolution and Site-Directed Mutagenesis
Drug Metab. Dispos., December 1, 2006; 34(12): 1958 - 1965.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Sridar, Y. Kobayashi, H. Brevig, U. M. Kent, S. G. Puppali, J. M. Rimoldi, and P. F. Hollenberg
Synthesis of Substituted Phenyl Diaziridines and Characterization as Mechanism-Based Inactivators of Human Cytochrome P450 2B6
Drug Metab. Dispos., November 1, 2006; 34(11): 1849 - 1855.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
M. A. Hummel, T. S. Tracy, J. M. Hutzler, J. L. Wahlstrom, Y. Zhou, and D. A. Rock
Influence of Fluorescent Probe Size and Cytochrome b5 on Drug-Drug Interactions in CYP2C9
J Biomol Screen, April 1, 2006; 11(3): 303 - 309.
[Abstract] [PDF]


Home page
J EndocrinolHome page
M K Akhtar, S L Kelly, and M A Kaderbhai
Cytochrome b5 modulation of 17{alpha} hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis
J. Endocrinol., November 1, 2005; 187(2): 267 - 274.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.